MoonLake Immunotherapeutics

MLTX· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences

$12.39+0.32%

2026-09-18

Financials

Valuation Metrics

MoonLake Immunotherapeutics's Market Cap is $912M. At end of 2025 it was $850M. Ranked #2524 of 3,121 in US market (top 81%), #1048 of 1,463 on NASDAQ (top 72%), #194 of 266 in Pharmaceuticals, Biotechnology & Life Sciences (top 73%) by Market Cap.

Investment Metrics(as of 2026-09-18)

Metric	Value	Rank
Size
Market Cap	$912M	US#2,524/3,121 Sec#194/266
Revenue	$0.00	US#2,889/3,121 Sec#196/266
Net Income	$-264M	US—/3,121 Sec—/266
Total Assets	$574M	US#2,713/3,121 Sec#145/266
Net Assets	$428M	US#2,336/3,121 Sec#126/266
Value
P/B	2.13x	US#1,326/3,121 Sec#56/266
FCF Yield	-24.69%	US—/3,121 Sec—/266
Profitability
ROE	-61.58%	US#2,724/3,121 Sec#175/266
ROA	-45.94%	US#2,973/3,121 Sec#202/266
Financial Health
Debt Ratio	34.04%	US#387/3,121 Sec#116/266
Total Debt	$102M	US#2,439/3,121 Sec#119/266
FCF	$-225M	US#2,799/3,121 Sec#216/266
Cash	$478M	US#1,105/3,121 Sec#59/266
Current Ratio	12.56x	US#200/3,121 Sec#63/266
Performance
1Y Return	-77.12%	US#3,095/3,121 Sec#265/266
1M Return	-25.99%	US#3,036/3,121 Sec#252/266
From 52W High	-80.25%	US#3,084/3,121 Sec#262/266
1Y MDD	-89.92%	US#3,112/3,121 Sec#263/266
Trading
Volume	1,756,859 shares	US#783/3,121 Sec#80/266
Trading Value	$22M	US#1,694/3,121 Sec#133/266
Per Share
EPS	$-3.58	US—/3,121 Sec—/266
BPS	$5.82	US#2,215/3,121 Sec#118/266